China Biologic Privatization Transaction Led by Centurium Capital Wins AVCJ "Deal of the Year - Large Cap"

Provided By PR Newswire

Last update: Nov 17, 2021

HONG KONG, Nov. 16, 2021 /PRNewswire/ -- The Centurium Capital-led privatization of leading plasma-based biopharmaceutical company China Biologic Products Holdings Inc. ("China Biologic" or the "Company") was awarded "Deal of the Year – Large Cap" by Asia Venture Capital Journal (AVCJ) at its annual award ceremony on November 15 in Hong Kong.